Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$488K Buy
4,111
+3,458
+530% +$443K 0.02% 411
2021
Q4
$100K Buy
653
+123
+23% +$19.2K ﹤0.01% 1080
2021
Q3
$74K Buy
530
+387
+271% +$55.5K ﹤0.01% 1088
2021
Q2
$20K Sell
143
-168
-54% -$23.4K ﹤0.01% 1126
2021
Q1
$41K Buy
311
+141
+83% +$18.5K ﹤0.01% 1080
2020
Q4
$19K Sell
170
-50
-23% -$5.16K ﹤0.01% 1051
2020
Q3
$20K Sell
220
-245
-53% -$23.5K ﹤0.01% 1020
2020
Q2
$40K Buy
465
+51
+12% +$3.96K ﹤0.01% 951
2020
Q1
$31K Buy
414
+81
+24% +$8.1K ﹤0.01% 774
2019
Q4
$38K Sell
333
-739
-69% -$79.1K ﹤0.01% 564
2019
Q3
$107K Sell
1,072
-1,046
-49% -$115K ﹤0.01% 543
2019
Q2
$257K Buy
+2,118
New +$228K 0.01% 512

Other funds holding JBTM

IndexIQ Advisors's JBTM Position: Q1 2022 in Review

IndexIQ Advisors increased its JBT Marel (JBTM) stake by 530% in Q1 2022, buying an estimated $443K and bringing the position to 4,111 shares worth $488K. The position accounts for 0.02% of the portfolio, ranked #411.

IndexIQ Advisors first reported a position in JBTM in Q2 2019 and has held it in 12 quarters since. 282 funds tracked by Wall St. Rank hold JBTM as of Q1 2022.

  • IndexIQ Advisors held 4,111 shares of JBT Marel worth $488K as of Q1 2022.
  • IndexIQ Advisors bought 3,458 JBT Marel shares in Q1 2022, an estimated $443K.
  • JBT Marel made up 0.02% of IndexIQ Advisors's portfolio in Q1 2022, its #411 holding.
  • IndexIQ Advisors first reported a position in JBT Marel in Q2 2019 and has held it in 12 quarters since.
  • 282 funds tracked by Wall St. Rank held JBT Marel as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.